NCT00597909 2024-12-17
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Amgen
Phase 2 Terminated
Amgen
Case Comprehensive Cancer Center
University of Missouri-Columbia
G1 Therapeutics, Inc.
University of Arkansas
Karolinska Institutet